KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Short-Term Debt repayments

Daily Values

Growth Metrics

Organon (OGN) Share-based Compensation (2020 - 2026)

Organon has reported Share-based Compensation over the past 7 years, most recently at $19.0 million for Q1 2026.

For Q1 2026, Share-based Compensation fell 20.83% year-over-year to $19.0 million; the TTM value through Mar 2026 reached $72.0 million, down 30.1%, while the annual FY2025 figure was $77.0 million, 26.67% down from the prior year.
Share-based Compensation for Q1 2026 was $19.0 million at Organon, up from $7.0 million in the prior quarter.
Over five years, Share-based Compensation peaked at $28.0 million in Q2 2024 and troughed at $7.0 million in Q4 2025.
A 5-year average of $22.2 million and a median of $24.0 million in 2025 define the central range for Share-based Compensation.
Biggest five-year swings in Share-based Compensation: skyrocketed 53.33% in 2022 and later plummeted 73.08% in 2025.
Year by year, Share-based Compensation stood at $23.0 million in 2022, then grew by 17.39% to $27.0 million in 2023, then decreased by 3.7% to $26.0 million in 2024, then plummeted by 73.08% to $7.0 million in 2025, then surged by 171.43% to $19.0 million in 2026.
Business Quant data shows Share-based Compensation for OGN at $19.0 million in Q1 2026, $7.0 million in Q4 2025, and $24.0 million in Q3 2025.